Well I'm looking forward to seeing what progress has been made in the last few months. Meanwhile some poor buggers got mugged of their shares at $6.10 this afternoon...Ouch, I think that's gonna hurt!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling